Loading...
PainChek Limited
PCK.AX•ASX
Healthcare
Medical - Healthcare Information Services
A$0.04
A$0.00(0.00%)
PainChek Limited (PCK.AX) Financial Performance & Income Statement Overview
Review PainChek Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
37.06%
↑ 37.06%
Operating Income Growth
-8.58%
↓ 8.58%
Net Income Growth
-9.68%
↓ 9.68%
Operating Cash Flow Growth
-12.73%
↓ 12.73%
Operating Margin
-315.25%
↓ 315.25%
Gross Margin
28.30%
↑ 28.30%
Net Profit Margin
-269.86%
↓ 269.86%
ROE
-452.57%
↓ 452.57%
ROIC
-411.46%
↓ 411.46%
PainChek Limited (PCK.AX) Income Statement & Financial Overview
Review PainChek Limited's (PCK.AX) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $1.66M | $1.37M | $1.30M | $1.17M |
| Cost of Revenue | $1.13M | $1.04M | $903920.00 | $615221.00 |
| Gross Profit | $529885.00 | $326701.00 | $399957.00 | $557457.00 |
| Gross Profit Ratio | $0.32 | $0.24 | $0.31 | $0.48 |
| R&D Expenses | $2.07M | $2.35M | $2.23M | $2.26M |
| SG&A Expenses | $2.99M | $2.99M | $2.68M | $2.82M |
| Operating Expenses | $5.06M | $5.34M | $4.91M | $5.07M |
| Total Costs & Expenses | $6.19M | $6.38M | $5.81M | $5.69M |
| Interest Income | $0.00 | $0.00 | $0.00 | $6351.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $12785.00 | $17078.00 | $8492.00 | $9771.00 |
| EBITDA | -$3.15M | -$4.99M | -$4.51M | -$4.50M |
| EBITDA Ratio | -$1.90 | -$3.65 | -$3.46 | -$3.81 |
| Operating Income | -$4.53M | -$5.009M | -$4.51M | -$4.51M |
| Operating Income Ratio | -$2.73 | -$3.66 | -$3.46 | -$3.85 |
| Other Income/Expenses (Net) | $1.37M | $0.00 | $2.00 | $15304.00 |
| Income Before Tax | -$3.16M | -$5.009M | -$4.51M | -$4.50M |
| Income Before Tax Ratio | -$1.90 | -$3.66 | -$3.46 | -$3.84 |
| Income Tax Expense | $0.00 | $0.00 | -$1.21M | -$30079.00 |
| Net Income | -$3.16M | -$5.009M | -$3.30M | -$4.47M |
| Net Income Ratio | -$1.90 | -$3.66 | -$2.53 | -$3.81 |
| EPS | -$0.002 | -$0.003 | -$0.002 | -$0.003 |
| Diluted EPS | -$0.002 | -$0.003 | -$0.002 | -$0.003 |
| Weighted Avg Shares Outstanding | $1.65B | $1.55B | $1.36B | $1.30B |
| Weighted Avg Shares Outstanding (Diluted) | $1.65B | $1.55B | $1.36B | $1.30B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan